ERC Starting Grant · 2024
Nature is a remarkable pharmaceutical chemist. More than 50% of approved drugs are natural products (NPs) or have drawn inspiration from them. According to the central dogma of bacterial NP biosynthesis all transformations responsible for the formation and modification of a NP scaffold are carried out by enzymes encoded in a biosynthetic gene cluster (BGC). Sophisticated genome mining algorithms have been developed to identify NP BGCs in microbial genome sequences. These algorithms excel in recognizing canonical BGCs. Non-canonical BGCs associated with NPs that are not biosynthesized following textbook biosynthetic knowledge evade detection by state-of-the-art genome mining algorithms. We…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.